sarpogrelate has been researched along with Coronary Vasospasm in 2 studies
sarpogrelate: structure given in first source
Coronary Vasospasm: Spasm of the large- or medium-sized coronary arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SR | 1 |
| Choi, KH | 1 |
| Song, YB | 1 |
| Lee, JM | 1 |
| Park, TK | 1 |
| Yang, JH | 1 |
| Hahn, JY | 1 |
| Choi, JH | 1 |
| Choi, SH | 1 |
| Gwon, HC | 1 |
| Miyata, K | 1 |
| Shimokawa, H | 1 |
| Higo, T | 1 |
| Yamawaki, T | 1 |
| Katsumata, N | 1 |
| Kandabashi, T | 1 |
| Tanaka, E | 1 |
| Takamura, Y | 1 |
| Yogo, K | 1 |
| Egashira, K | 1 |
| Takeshita, A | 1 |
1 trial available for sarpogrelate and Coronary Vasospasm
| Article | Year |
|---|---|
Effect of sarpogrelate and high-dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Vasospasm; Dose-Response Relationship, | 2019 |
1 other study available for sarpogrelate and Coronary Vasospasm
| Article | Year |
|---|---|
Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model.
Topics: Angiography; Animals; Base Sequence; Coronary Vasospasm; Dinoprost; Disease Models, Animal; Dose-Res | 2000 |